Encision OTC Stock Executives

ECIA -  USA Stock  

USD 1.49  0.01  0.68%

Encision employes about 30 people. The company is managed by 11 executives with total tenure of roughly 134 years, averaging almost 12.0 years of service per executive having 2.73 employees per reported executive. Analysis of Encision management performance can provide insight into the company performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Encision future performance.
Continue to Investing Opportunities.

Encision Insiders 

  Gregory Trudel  CEO
CEO and President and Director
  Patrick Pace  Chairman
Executive Chairman of the Board
  Brad Greathouse  President
Vice President - Regulatory Affairs & Quality Assurance

Encision Return on Sales


Encision Management Team Effectiveness

Encision has return on total asset (ROA) of (0.73) % which means that it has lost $0.73 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 23.47 %, meaning that it created $23.47 on every $100 dollars invested by stockholders. Encision management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. The current year Return on Average Assets is expected to grow to 0.12. The current year Return on Average Equity is expected to grow to 0.27. Encision Goodwill and Intangible Assets are projected to decrease significantly based on the last few years of reporting. The past year's Goodwill and Intangible Assets were at 213,368. The current year Asset Turnover is expected to grow to 1.64, whereas Total Assets are forecasted to decline to about 5 M.
The current year Weighted Average Shares is expected to grow to about 11.7 M. The current year Weighted Average Shares Diluted is expected to grow to about 11.8 M

Encision Workforce Comparison

Encision is one of the top stocks in number of employees category among related companies. The total workforce of Medical Instruments & Supplies industry is currently estimated at about 135,367. Encision adds roughly 30.0 in number of employees claiming only tiny portion of all equities under Medical Instruments & Supplies industry.

Encision Profit Margins

The company has Profit Margin (PM) of 7.76 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (0.81) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.01.

Encision Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Encision insiders, such as employees or executives, is commonly permitted as long as it does not rely on Encision's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Encision insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Encision Benchmark Summation

The output start index for this execution was four with a total number of output elements of fifty-seven. The Highest value over a specified period line plots max value of Encision price series. View also all equity analysis or get more info about highest value over a specified period math operators indicator.

Encision Notable Stakeholders

An Encision stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Encision often face trade-offs trying to please all of them. Encision's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Encision's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Gregory Trudel - CEO and President and DirectorProfile
Patrick Pace - Executive Chairman of the BoardProfile
Brad Greathouse - Vice President - Regulatory Affairs & Quality AssuranceProfile
Peter Geary - Vice President - OperationsProfile
Robert Fries - Independent DirectorProfile
Ruediger NaumannEtienne - Independent DirectorProfile
David Newton - Co-Founder, VP of Technology and DirectorProfile
Vern Kornelsen - Independent DirectorProfile
Michael Biggs - VP of EngineeringProfile
Valerie Ray - VP of OperationsProfile
Mala Ray - Controller, Treasurer and Corporate SecretaryProfile

About Encision Management Performance

The success or failure of an entity such as Encision often depends on how effective the management is. Encision management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Encision management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Encision management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please read more on our stock advisor page.
Last ReportedProjected for 2021
Return on Average Assets 0.11  0.12 
Return on Average Equity 0.24  0.27 
Return on Invested Capital 0.19  0.21 
Return on Sales 0.09  0.1 
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company was founded in 1991 and is based in Boulder, Colorado. Encision operates under Medical Devices classification in the United States and is traded on OTC Exchange.
The data published in Encision's official financial statements usually reflect Encision's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Encision. For example, before you start analyzing numbers published by Encision accountants, it's critical to develop an understanding of what Encision's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Encision's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Encision's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Encision's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Encision. Please utilize our Beneish M Score to check the likelihood of Encision's management to manipulate its earnings.

Encision Workforce Analysis

Traditionally, organizations such as Encision use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Encision within its industry.

Encision Manpower Efficiency

Return on Encision Manpower

Revenue Per Employee251.3 K
Revenue Per Executive685.5 K
Net Income Per Employee19.5 K
Net Income Per Executive53.2 K
Working Capital Per Employee47.4 K
Working Capital Per Executive129.2 K
Continue to Investing Opportunities. Note that the Encision information on this page should be used as a complementary analysis to other Encision's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Encision OTC Stock analysis

When running Encision price analysis, check to measure Encision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Encision is operating at the current time. Most of Encision's value examination focuses on studying past and present price action to predict the probability of Encision's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Encision's price. Additionally, you may evaluate how the addition of Encision to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Correlations
Find global opportunities by holding instruments from different markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
The market value of Encision is measured differently than its book value, which is the value of Encision that is recorded on the company's balance sheet. Investors also form their own opinion of Encision's value that differs from its market value or its book value, called intrinsic value, which is Encision's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Encision's market value can be influenced by many factors that don't directly affect Encision underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Encision's value and its price as these two are different measures arrived at by different means. Investors typically determine Encision value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Encision's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.